CDI(CODX) - 2024 Q4 - Annual Results

Exhibit 99.1 Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results SALT LAKE CITY, March 27, 2025— Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the fourth quarter and full year ended December 31, 2024. Full Year 2024 Financial Results: Full Year 2024 and Recent Business Highlights: ● Revenue of $3.9 million, which declined from$6.8 million during the prio ...